Related Experiment Video
Updated: Jun 17, 2026

Real-Time Monitoring of Aurora kinase A Activation using Conformational FRET Biosensors in Live Cells
Published on: July 30, 2020
A pharmacodynamic model of Aurora kinase inhibitors in the spindle assembly checkpoint
Hitesh B Mistry1, David E MacCallum, Robert C Jackson
1Division of Mathematics, University of Dundee, Dundee DD1 4HN, Scotland, UK.
Abstract:
Arguably the most dramatic phase in the cell cycle is mitosis, during which replicated chromosomes are sorted into two distinct sets. Aurora kinases are central to the accurate segregation of chromosomes during mitosis. Consequently, they have been selected as possible targets for cancer therapy. Anti-cancer drugs that target Aurora kinases are normally designed to inhibit their function. The complexity of the roles of Aurora kinases and their interaction with respective inhibitors means that it is often very difficult to obtain meaningful links between inhibitor concentration and efficacy using standard methods. To overcome these difficulties, we propose a novel mathematical modelling approach. We present a pharmacodynamic model that is able to encapsulate the key roles of two kinases, Aurora A and B, in the spindle assembly checkpoint. Moreover, the model is capable of qualitatively differentiating between the effects of inhibiting Aurora A, Aurora B and A plus B, respectively, by predicting cell behaviour. Consequently, predictions regarding the qualitative relationship between inhibitors, measurable biomarkers and cell damage can be obtained using this powerful modelling approach.
Insights
Mathematical modeling offers a novel way to understand how inhibiting Aurora kinases affects cell division during mitosis. This approach helps predict cancer drug efficacy by linking inhibitor concentration to cell damage.
Area of Science:
- Cell Biology
- Pharmacology
- Mathematical Biology
Background:
- Mitosis is crucial for accurate chromosome segregation, with Aurora kinases playing a central role.
- Aurora kinases are key targets for cancer therapy, but their complex functions complicate drug development.
- Standard methods struggle to link Aurora kinase inhibitor concentration to treatment efficacy.
Purpose of the Study:
- To develop a novel mathematical modeling approach to study Aurora kinases in mitosis.
- To create a pharmacodynamic model for Aurora A and B kinases within the spindle assembly checkpoint.
- To differentiate the effects of inhibiting Aurora A, Aurora B, or both on cell behavior.
Main Methods:
- Developed a pharmacodynamic mathematical model.
- Encapsulated key roles of Aurora A and B kinases in the spindle assembly checkpoint.
- Used the model to predict cell behavior under different inhibition scenarios.
Main Results:
- The model qualitatively differentiates the effects of inhibiting Aurora A, Aurora B, and dual inhibition.
- Predicted cell behavior provides insights into the relationship between inhibitors and cell damage.
- Enabled predictions linking inhibitor concentration, biomarkers, and cell damage.
Conclusions:
- Mathematical modeling provides a powerful approach to understand Aurora kinase inhibitor effects.
- This method can predict qualitative relationships between drug concentration, biomarkers, and cell damage.
- Offers a new strategy for developing targeted cancer therapies involving Aurora kinases.
Related Concept Videos
The Spindle Assembly Checkpoint
Many proteins function together to control the spindle assembly checkpoint. Mutations affecting these proteins may allow cells to proceed into anaphase prematurely, resulting in the...
The Spindle Assembly Checkpoint
Many proteins function together to control the spindle assembly checkpoint. Mutations affecting these proteins may allow cells to proceed into anaphase prematurely, resulting in the...
Anaphase Promoting Complex
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Inhibition of Cdk Activity
Inhibition of CDK Activity

